Cargando…
Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis
Portal hypertension (PHT) is one of the most severe consequences of liver cirrhosis. Carvedilol is a first-line pharmacological treatment of PHT. However, the antifibrogenic effects of carvedilol on liver cirrhosis and the intrinsic mechanisms underlying these effects have not been thoroughly invest...
Autores principales: | Ling, Liping, Li, Guangqi, Wang, Guangchuan, Meng, Dongxiao, Li, Zhen, Zhang, Chunqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625452/ https://www.ncbi.nlm.nih.gov/pubmed/31257490 http://dx.doi.org/10.3892/mmr.2019.10401 |
Ejemplares similares
-
Carvedilol Ameliorates Intrahepatic Angiogenesis, Sinusoidal Remodeling and Portal Pressure in Cirrhotic Rats
por: Ling, Liping, et al.
Publicado: (2018) -
Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway
por: Wu, Ying, et al.
Publicado: (2019) -
Doxazosin and Carvedilol Treatment Improves Hepatic Regeneration in a Hamster Model of Cirrhosis
por: Serna-Salas, Sandra Alejandra, et al.
Publicado: (2018) -
Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis
por: Li, Tong, et al.
Publicado: (2016) -
Severe carvedilol toxicity without overdose – caution in cirrhosis
por: Maharaj, Satish, et al.
Publicado: (2017)